Heartbeam Market Capitalization from 2010 to 2024
| BEAT Stock | USD 3.06 0.21 7.37% |
Check Heartbeam financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heartbeam's main balance sheet or income statement drivers, such as Depreciation And Amortization of 10.4 M, Selling And Marketing Expenses of 9.3 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 5.06, Dividend Yield of 0.0 or PTB Ratio of 3.15. Heartbeam financial statements analysis is a perfect complement when working with Heartbeam Valuation or Volatility modules.
Heartbeam | Market Capitalization |
Latest Heartbeam's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Heartbeam over the last few years. It is Heartbeam's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heartbeam's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 81.6 M | 10 Years Trend |
|
Market Cap |
| Timeline |
Heartbeam Market Capitalization Regression Statistics
| Arithmetic Mean | 60,189,987 | |
| Geometric Mean | 41,233,903 | |
| Coefficient Of Variation | 120.41 | |
| Mean Deviation | 46,357,323 | |
| Median | 34,082,316 | |
| Standard Deviation | 72,475,251 | |
| Sample Variance | 5252.7T | |
| Range | 241.2M | |
| R-Value | (0.38) | |
| Mean Square Error | 4852.4T | |
| R-Squared | 0.14 | |
| Significance | 0.17 | |
| Slope | (6,110,833) | |
| Total Sum of Squares | 73537.3T |
Heartbeam Market Capitalization History
About Heartbeam Financial Statements
Heartbeam shareholders use historical fundamental indicators, such as Market Capitalization, to determine how well the company is positioned to perform in the future. Although Heartbeam investors may analyze each financial statement separately, they are all interrelated. The changes in Heartbeam's assets and liabilities, for example, are also reflected in the revenues and expenses on on Heartbeam's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company was incorporated in 2015 and is headquartered in Santa Clara, California. Heartbeam operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 5 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Heartbeam Stock Analysis
When running Heartbeam's price analysis, check to measure Heartbeam's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heartbeam is operating at the current time. Most of Heartbeam's value examination focuses on studying past and present price action to predict the probability of Heartbeam's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heartbeam's price. Additionally, you may evaluate how the addition of Heartbeam to your portfolios can decrease your overall portfolio volatility.